Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CIC Mauricie conducts phase II–IV clinical trials primarily focused on respiratory diseases and allergies. The center has a strong reputation for professionalism and patient-centered care. It collaborates with major pharmaceutical companies to test new therapies across a broad regional network in Quebec. Over ten protocols are run annually at the site with increasing subject participation. The team includes general practitioners specialized in pulmonology/allergies and several research coordinators. No specific drug results are published by the center itself; it acts as a research site for sponsor-led studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CIC Mauricie.